Intraneuronal Abeta42 accumulation in human brain.

It is suggested that intracellular Abeta42 accumulation is an early event in neuronal dysfunction and that preventing intraneuronal Abeta 42 aggregation may be an important therapeutic direction for the treatment of AD.